| Name | Sodium phenylbutyrate | CAS# | 1716-12-7 | |
|---|---|---|---|---|
| Price | ¥Inquiry/1g | Purity | 98.9% | |
| Stocking Period |
1 Day | Stock | In Stock |
| Detail
Product Information
Sodium phenylbutyrate is used to treat urea cycle disorders, because its metabolites offer an alternative pathway to the urea cycle to allow excretion of excess nitrogen. It is an orphan drug, marketed by Ucyclyd Pharma under the trade name Buphenyl, by Swedish Orphan International (Sweden) as Ammonaps, and by Fyrlkl?vern Scandinavia as triButyrate. Sodium phenylbutyrate is also a histone deacetylase inhibitor and chemical chaperone, leading respectively to research into its use as an anti-cancer agent and in protein misfolding diseases such as cystic fibrosis. |
Get all suppliers by the below link:
Sodium phenylbutyrate suppliers
| 2024-07-15 |
Sodium phenylbutyrate
Price: Inquiry |
| 2019-03-05 |
Sodium phenylbutyrate
Price: ¥2506.0 |
| 2020-12-18 |
Sodium phenylbutyrate
Price: $Inquiry |
| 2021-07-26 |
Sodium 4-phenylbutyrate
Price: $Inquiry |
| 2024-01-09 |
Sodium 4-phenylbutyrate
Price: $Inquiry |
| 2017-10-18 |
Sodium phenylbutyrate
Price: ¥6000.0 |
| 2024-05-11 |
Sodium phenylbutyrate
Price: ¥Inquiry |
| 2023-11-13 |
Sodium phenylbutyrate
Price: ¥Inquiry |
| 2021-02-06 |
Sodium Phenylbutyrate
Price: ¥789.0 |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved


